# EnCureGen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/encuregen

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Latest round: Seed (Jun 8, 2023)
- Investors on record: 4

## About

Based in Guangzhou, China, and founded in 2023, EnCureGen operates as a biotechnology company that focuses on the development of innovative mRNA drugs. The founder of the company, Aimin Hui, worked as the CEO of Fosun Pharmaceutical. In June 2023, EnCureGen completed a seed funding from new investors Triwise Capital, Guangzhou Guoju Venture Capital, Redhill Capital, and Gdd Industry Fund.

EnCureGen is engaged in the development of innovative mRNA drugs for oncology and immunology as well as vaccines for infectious diseases. The company also builds the technology platform for mRNA.

## Funding rounds

- Seed, Jun 8, 2023 — Triwise Capital, Guangzhou Guoju Venture Capital, Redhill Capital, Guangzhou Development District City Development Fund

## Investors

- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Seed
- Guangzhou Guoju Venture Capital (https://capitalatlas.ai/funds/guangzhou-guoju-venture-capital) — Seed
- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Seed
- Guangzhou Development District City Development Fund (https://capitalatlas.ai/funds/guangzhou-development-district-city-development-fund) — Seed